Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification
- 375 Downloads
Previous studies found that neuron specific enolase promoter (Nse-BMP4) transgenic mice have increased expression of the nociceptive mediator, substance P and exaggerated local injury responses associated with heterotopic ossification (HO). It is of interest great to know the pain responses in these mice and how the opioid signaling is involved in the downstream events such as mast cell (MC) activation.
Materials and methods
This study utilized a transgenic mouse model of HO in which BMP4 is expressed under the control of the Nse-BMP4. The tactile sensitivity and the cold sensitivity of the mice were measured in a classic inflammatory pain model (carrageenan solution injected into the plantar surface of the left hind paw). The MC activation and the expression profiles of different components in the opioid signaling were demonstrated through routine histology and immunohistochemistry and Western blotting, in the superficial and deep muscle injury models.
We found that the pain responses in these mice were paradoxically attenuated or unchanged, and we also found increased expression of both Methionine Enkephalin (Met-Enk), and the μ-opioid receptor (MOR). Met-Enk and MOR both co-localized within activated MCs in limb tissues. Further, Nse-BMP4;MOR−/− double mutant mice showed attenuated MC activation and had a significant reduction in HO formation in response to injuries.
These observations suggest that opioid signaling may play a key role in MC activation and the downstream inflammatory responses associated with HO. In addition to providing insight into the role of MC activation and associated injury responses in HO, these findings suggest opioid signaling as a potential therapeutic target in HO and possibly others disorders involving MC activation.
KeywordsMast cell (MC) Bone morphogenetic protein (BMP) Heterotopic ossification (HO) Substance P (SP) μ-Opioid receptor (MOR) Methionine enkephalin (Met-Enk)
We appreciate the help from many members of the Kessler Laboratory. LK was supported in part by grants from The Center for Research in FOP and Related Disorders of the University of Pennsylvania School of Medicine, and by NIH grant NS 20013 to JAK, and NS057704 to AVA.
- 1.Ramalho LS, Oliveira LF, Cavellani CL, Ferraz ML, de Oliveira FA, Miranda Correa RR, et al. Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases. Ann Diagn Pathol. 2013;17(1):28–31. doi: 10.1016/j.anndiagpath.2012.04.007.PubMedCrossRefGoogle Scholar
- 18.Tramullas M, Lantero A, Diaz A, Morchon N, Merino D, Villar A, et al. BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-beta family in pain modulation. J Neurosci. 2010;30(4):1502–11. doi: 10.1523/JNEUROSCI.2584-09.2010.PubMedCrossRefGoogle Scholar
- 29.Poonawala T, Levay-Young BK, Hebbel RP, Gupta K. Opioids heal ischemic wounds in the rat. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair. Wound Repair Regen. 2005;13(2):165–74. doi: 10.1111/j.1067-1927.2005.130207.x.PubMedCrossRefGoogle Scholar